Eagle Asset Management’s Kura Oncology KURA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-375,493	Closed	-$4.59M	–	552
2023 Q1	$4.59M	Sell	375,493 -32,007	-8%	-$399K	0.03%	352
2022 Q4	$4.91M	Sell	407,500 -313,138	-43%	-$4.55M	0.03%	339
2022 Q3	$9.84M	Sell	720,638 -21,689	-3%	-$335K	0.06%	241
2022 Q2	$13.6M	Sell	742,327 -28,562	-4%	-$411K	0.09%	211
2022 Q1	$12.4M	Buy	770,889 +33,470	+5%	+$483K	0.06%	244
2021 Q4	$10.5M	Sell	737,419 -63,435	-8%	-$1.03M	0.05%	302
2021 Q3	$15M	Sell	800,854 -359	-0%	-$6.76K	0.07%	246
2021 Q2	$16.7M	Sell	801,213 -43,977	-5%	-$1.09M	0.07%	257
2021 Q1	$24.8M	Buy	845,190 +55,226	+7%	+$1.75M	0.11%	220
2020 Q4	$25.8M	Sell	789,964 -713,487	-47%	-$25.1M	0.15%	200
2020 Q3	$45.9M	Sell	1,503,451 -501,002	-25%	-$11.1M	0.24%	151
2020 Q2	$33.3M	Sell	2,004,453 -42,531	-2%	-$614K	0.19%	174
2020 Q1	$20.4M	Sell	2,046,984 -14,693	-0.7%	-$168K	0.13%	206
2019 Q4	$28.3M	Sell	2,061,677 -14,070	-0.7%	-$208K	0.14%	211
2019 Q3	$31.5M	Buy	2,075,747 +31,878	+2%	+$567K	0.16%	194
2019 Q2	$40.2M	Sell	2,043,869 -4,839	-0.2%	-$80.3K	0.21%	180
2019 Q1	$34M	Buy	2,048,708 +14,317	+0.7%	+$221K	0.18%	198
2018 Q4	$28.6M	Sell	2,034,391 -36,026	-2%	-$477K	0.18%	201
2018 Q3	$36.2M	Buy	2,070,417 +703,282	+51%	+$13.5M	0.18%	199
2018 Q2	$24.9M	Buy	+1,367,135	New	+$23.2M	0.13%	220

Other funds holding KURA